Literature DB >> 9278188

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.

S E Bachus1, T M Hyde, M M Herman, M F Egan, J E Kleinman.   

Abstract

Limbic cortical regions, including anterior cingulate cortex (ACC), prefrontal cortex (PFC) and entorhinal cortex (ERC), have been implicated in the neuropathology of schizophrenia. Glutamate projection neurons connect these limbic cortical regions to each other, as well as to the terminal fields of the striatal/accumbens dopamine neurons. Subsets of these glutamate projection neurons, and of the GABA interneurons in cortex, contain the neuropeptide cholecystokinin (CCK). In an effort to study the limbic cortical glutamate projection neurons and GABA interneurons in schizophrenia, we have measured CCK mRNA with in situ hybridization histochemistry in postmortem samples of dorsolateral (DL)PFC, ACC and ERC of seven schizophrenics, nine non-psychotic suicides and seven normal controls. CCK mRNA is decreased in ERC (especially layers iii vi) and subiculum in schizophrenics relative to controls. Cellular analysis indicates that there is a decrease in density of CCK mRNA in labelled neurons. In so far as ERC CCK mRNA is not reduced in rats treated chronically with haloperidol, this decrease in schizophrenics does not appear to be related to neuroleptic treatment. In contrast, in DLPFC, where schizophrenics do not differ from normals, the suicide victims have elevated CCK mRNA (especially in layers v and vi), and increased cellular density of CCK mRNA, relative to both normals and schizophrenics. These results lend further support for the involvement of ERC and hippocampus in schizophrenia, suggesting that neurons that utilize CCK may be particularly important. Similarly, an increase in CCK mRNA levels in the PFC of suicides adds to a growing body of evidence implicating this structure in this pathological state. In so far as CCK is co-localized with GABA or glutamate in cortical neurons, both of these neuronal populations need to be studied further in schizophrenia and suicide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278188     DOI: 10.1016/s0022-3956(96)00041-6

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  16 in total

1.  Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.

Authors:  Shouping Wang; An-Ping Zhang; Lalitha Kurada; Toshimitsu Matsui; Saobo Lei
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

2.  Neurobiology of suicidal behavior. An integration of biological and clinical findings.

Authors:  Juan J Carballo; Chibuikem P Akamnonu; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2008

3.  Regional differences in expression of β-tubulin isoforms in schizophrenia.

Authors:  Mark S Moehle; Richard F Luduena; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2012-01-20       Impact factor: 4.939

Review 4.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

Review 5.  Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells.

Authors:  Erik Keimpema; Alex Straiker; Ken Mackie; Tibor Harkany; Jens Hjerling-Leffler
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

6.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

7.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

8.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

9.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

10.  Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness.

Authors:  Mark O Cunningham; Jillian Hunt; Steven Middleton; Fiona E N LeBeau; Martin J Gillies; Martin G Gillies; Ceri H Davies; Peter R Maycox; Miles A Whittington; Claudia Racca
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.